🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

RecruitingNCT05919433

Detection Program for Patients With Primary Biliary Cholangitis Lost in the System

🏥 Hospital Mutua de Terrassa📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06122285

Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)

🏥 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 1 site📅 Started May 2023View details ↗
Phase 3RecruitingNCT05860868

Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma

🏥 First Affiliated Hospital, Sun Yat-Sen University📍 1 site📅 Started May 2023View details ↗
Phase 3RecruitingNCT05378555

Oral Ketamine for Treatment of Vaso-Occlusive Pain

🏥 Boston Children's Hospital📍 1 site📅 Started May 2023View details ↗
RecruitingNCT05345795

Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis

🏥 Central Hospital, Nancy, France📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05741853

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

👨‍⚕️ Stephanie M Grasso, Ph.D, University of Texas at Austin📍 3 sites📅 Started May 2023View details ↗
NARecruitingNCT05184296

ExtraCorporeal Membrane Oxygenation in the Therapy for REfractory Septic Shock With Cardiac Function Under Estimated

👨‍⚕️ Zhen-hui Zhang, Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started May 2023View details ↗
RecruitingNCT05898477

Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis

👨‍⚕️ Gaurav Goyal, MD, University of Alabama at Birmingham📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06228001

Holter of Movement in Patients With Amyotrophic Lateral Sclerosis.

👨‍⚕️ Stéphanie Delstanche, MD, Centre de référence des maladies neuromusculaire, Centre Hospitalier Régional de la Citadelle📍 3 sites📅 Started May 2023View details ↗
Phase 4RecruitingNCT05806580

Secondary Infusion of Relma-cel Injection for Relapsed or Refractory B-cell Lymphoma

🏥 Ruijin Hospital📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06161428

Optical Guided Sentinel Node Biopsy for Staging of Vulvar Cancer

🏥 Rigshospitalet, Denmark📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06610019

Cardiovascular Multimodality Imaging Study

👨‍⚕️ Leandro Slipczuk, MD, PhD, Montefiore Medical Center📍 1 site📅 Started May 2023View details ↗
NARecruitingNCT05295615

Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's Disease

🏥 Herrick Medical LLC📍 1 site📅 Started May 2023View details ↗
RecruitingNCT06344650

Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.

🏥 IRCCS San Raffaele📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT06334835

Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.

👨‍⚕️ Giovanni Smaldone, PhD, IRCCS SYNLAB SDN📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT05843552

Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease

👨‍⚕️ Reena Kartha, PhD, MS, University of Minnesota📍 1 site📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT05688696

Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus

🏥 Beijing InnoCare Pharma Tech Co., Ltd.📍 41 sites📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT05615636

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

👨‍⚕️ Jason Westin, MD, MS, FACP, M.D. Anderson Cancer Center📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT05866783

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

🏥 University Hospital, Ghent📍 1 site📅 Started Apr 2023View details ↗
Phase 1, PHASE2RecruitingNCT05880043

GIC-102, Intravenous Allogeneic NK Cells, in Subjects With Advanced Solid Cancers and R/R Hematologic Malignancies

🏥 GI Cell, Inc.📍 4 sites📅 Started Apr 2023View details ↗
← PreviousPage 412 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →